Airway infection and Pseudomonas aeruginosa in bronchiectasis (cystic fibrosis and non-cystic fibrosis bronchiectasis)

QR Code

Airway infection and Pseudomonas aeruginosa in bronchiectasis (cystic fibrosis and non-cystic fibrosis bronchiectasis)

Overview Bronchiectasis is a term used to refer to dilatation of the bronchi that is often permanent and associated a chronic productive cough and recurrent respiratory infections. It is caused by a wide range of clinical disorders, both inherited and acquired [1]. Bronchiectasis is not itself a di...

Full description

Bibliographic Details
Main Author:	Webb, Karmel
Format:	Thesis (University of Nottingham only)
Language:	English English
Published:	2022
Subjects:	Bronchiectasis; P. aeruginosa infection; Disease progression factors; Pulmonary exacerbations; Clinical outcomes
Online Access:	https://eprints.nottingham.ac.uk/68639/

Similar Items

Minimal important difference in field walking tests in non-cystic fibrosis bronchiectasis following exercise training
by: Lee, A., et al.
Published: (2014)

Bronchiectasis and the risk of cardiovascular disease: a population-based study
by: Navaratnam, Vidya, et al.
Published: (2016)

Lectin-mediated biofilm maturation, quorum sensing and Pseudomonas aeruginosa infections in cystic fibrosis
by: Crusz, S.A.
Published: (2009)

Mitigating the harm caused by Pseudomonas aeruginosa in Cystic Fibrosis
by: Palser, Sally C.
Published: (2024)

Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis
by: Langton Hewer, Simon C., et al.
Published: (2014)

Novel approaches to the treatment of Pseudomonas aeruginosa infections in cystic fibrosis
by: Hurley, M.N., et al.
Published: (2012)

The association between Staphylococcus aureus and subsequent bronchiectasis in children with cystic fibrosis
by: Caudri, D., et al.
Published: (2018)

Inducible NO synthase expression is low in airway epithelium from young children with cystic fibrosis
by: Moeller, A., et al.
Published: (2006)

Surviving and thriving in the cystic fibrosis lung: contribution of an arginine specific aminopeptidase to sustained infection by Pseudomonas aeruginosa
by: Spencer, Daniella Lucy
Published: (2019)

Matrix metalloproteinase activation by free neutrophil elastase contributes to bronchiectasis progression in early cystic fibrosis
by: Garratt, L.W., et al.
Published: (2015)

Field Walking Tests Are Reliable and Responsive to Exercise Training in People With Non–Cystic Fibrosis Bronchiectasis
by: Lee, A., et al.
Published: (2015)

Identifying peroxidases and their oxidants in the early pathology of cystic fibrosis.
by: Thomson, E., et al.
Published: (2010)

The effects of pulmonary rehabilitation in patients with non-cystic fibrosis bronchiectasis: protocol for a randomised controlled trial
by: Lee, A., et al.
Published: (2010)

Respiratory viral infections in Western Australians with cystic fibrosis
by: Brestovac, Brian, et al.
Published: (2020)

Elastase exocytosis by airway neutrophils is associated with early lung damage in children with cystic fibrosis
by: Margaroli, C., et al.
Published: (2019)

Validity and Reliability of the Chronic Respiratory Disease Questionnaire in Elderly Individuals with Mild to Moderate Non-Cystic Fibrosis Bronchiectasis
by: Vodanovich, D., et al.
Published: (2015)

Cystic Fibrosis isolates of Pseudomonas aeruginosa retain iron-regulated antimicrobial activity against Staphylococcus aureus through the action of multiple alkylquinolones
by: Nguyen, Angela T., et al.
Published: (2016)

Hypoxia and sterile inflammation in cystic fibrosis airways: Mechanisms and potential therapies
by: Montgomery, S.T., et al.
Published: (2017)

POLYMICROBIAL INFECTION AND NEUTROPHILIC DISEASE IN CYSTIC FIBROSIS AIRWAYS
by: Laucirica, D.R., et al.
Published: (2019)

Understanding chronic inflammatory diseases in the human lung: the cystic fibrosis and idiopathic pulmonary fibrosis paradigms
by: Liu, Yi-Chia
Published: (2014)

An Official American Thoracic Society/European Respiratory Society Statement: Key Concepts and Advances in Pulmonary Rehabilitation
by: Spruit, M., et al.
Published: (2013)

Use of a primary epithelial cell screening tool to investigate phage therapy in cystic fibrosis
by: Trend, S., et al.
Published: (2018)

Delayed publications of clinical trials in cystic fibrosis
by: Hurley, M.N., et al.
Published: (2011)

Exhaled breath hydrogen cyanide as a marker of early Pseudomonas aeruginosa infection in children with cystic fibrosis
by: Gilchrist, Francis J., et al.
Published: (2015)

Pseudomonas aeruginosa quorum sensing molecules correlate with clinical status in cystic fibrosis
by: Barr, Helen L., et al.
Published: (2015)

Glutamine supplementation in cystic fibrosis: a randomized placebo-controlled trial
by: Forrester, Doug L., et al.
Published: (2015)

Synthesis and biological evaluation of novel PqsR antagonists to combat Pseudomonas aeruginosa infections
by: Mashabi, Alaa
Published: (2021)

HOST DEFENCE PEPTIDE AS AN INNOVATIVE NOVEL THERAPY FOR PSEUDOMONAS AERUGINOSA BIOFILM INFECTIONS IN THE CYSTIC FIBROSIS LUNG
by: Wannigama, D., et al.
Published: (2019)

The potential of phage therapy in cystic fibrosis: Essential human-bacterial-phage interactions and delivery considerations for use in Pseudomonas aeruginosa-infected airways
by: Trend, S., et al.
Published: (2017)

Inhibition of co-colonizing cystic fibrosis-associated pathogens by Pseudomonas aeruginosa and Burkholderia multivorans
by: Costello, A., et al.
Published: (2014)

Cardiovascular outcomes following a respiratory tract infection among adults with non-CF bronchiectasis: a general population based study
by: Navaratnam, Vidya, et al.
Published: (2018)

US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis
by: Floto, R. Andres, et al.
Published: (2016)

Critical care admission trends and outcomes in individuals with bronchiectasis in the UK
by: Navaratnam, Vidya, et al.
Published: (2015)

Synthesis and biological evaluation of novel PqsR antagonists to combat Pseudomonas aeruginosa infections
by: Mashabi, Alaa
Published: (2021)

Free neutrophil elastase activity in airways of young children with cystic fibrosis prior to, during and post-Pseudomonas infection
by: Garratt, L., et al.
Published: (2016)

An ex vivo lung model to study bronchioles infected with Pseudomonas aeruginosa biofilms
by: Harrison, Freya, et al.
Published: (2016)

Neutrophil Elastase Activity During Episodes Of Pseudomonas Infection In Early Cystic Fibrosis
by: Garratt, L.W., et al.
Published: (2016)

Association of Antibiotics, Airway Microbiome and Inflammation in Infants with Cystic Fibrosis.
by: Pittman, J., et al.
Published: (2017)

Recombination is a key driver of genomic and phenotypic diversity in a Pseudomonas aeruginosa population during cystic fibrosis infection
by: Darch, Sophie E., et al.
Published: (2015)

Perception of first respiratory infection with Pseudomonas aeruginosa by people with cystic fibrosis and those close to them: an online qualitative study
by: Palser, Sally C., et al.
Published: (2016)